#Galvanize Therapeutics

Venture Herald’s Galvanize Therapeutics archive gathers coverage of the company within the broader startup and venture capital landscape, with attention to its role in therapeutics and related innovation. It offers readers a concise entry point to reporting on the business, funding, and technology themes associated with the company.

Galvanize raises $130M Series D led by HealthQuest

Galvanize Therapeutics closed an oversubscribed $130 million Series D to expand Aliya, advance RheOx, and build its next PEF platform.

Nov 17, 2026 · 3 min